The correlation between the expression level of MRPL9 and the clinicopathological characteristics of PTC patients, such as age, gender, TNM stage, multifocality, distant metastasis, and lymph node metastasis, is shown in Table 1. The gene discussed is MRPL9; the disease is metastatic malignant neoplasm in the lymph nodes.